Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial.

Autor: Chew CK; Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia., Wang R; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Bavanandan S; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Zainudin N; Rheumatology Unit, Hospital Selayang, Selangor, Malaysia., Zhao X; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Ahmed S; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Nair D; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Hou L; Beijing Institute of Biotechnology, Beijing, China., Yahya R; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Ch'ng SS; Rheumatology Unit, Hospital Selayang, Selangor, Malaysia., Pang LH; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Abdul Aziz A; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Huang H; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Rajasuriar R; Immunotherapeutcis Laboratory and Department of Medicine, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia., Wu S; Beijing Institute of Biotechnology, Beijing, China., Zhang Z; Beijing Institute of Biotechnology, Beijing, China., Wang X; Shanghai ImStat Medical Technology Co., Ltd., Shanghai, China., Chun GY; Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia., Mohd Norzi A; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Cheah KY; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Lee YL; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Wan Mohamad WH; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Mohd Din MR; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Wan Ahmad Kamil WMR; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Tan MH; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Xu X; Nanjing Vazyme Biotech Co., Ltd., Nanjing, China., Wang L; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Yan M; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Liu Y; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Chin VK; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Teo JS; Clindata Consult Sdn Bhd, Petaling Jaya, Selangor, Malaysia., Lim TO; Clin Research Private Enterprise, Petaling Jaya, Selangor, Malaysia., Zhu T; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Gou J; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China. jinbo.gou@cansinotech.com., Ng SSM; Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia. sharonng@moh.gov.my.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Oct 31; Vol. 9 (1), pp. 209. Date of Electronic Publication: 2024 Oct 31.